7 results
10-K
2021 FY
XLO
Xilio Therapeutics Inc
1 Mar 22
Annual report
4:07pm
after the investigational drug or biologic receives designation as a Breakthrough Therapy, fast track product or regenerative medicine advanced
424B4
XLO
Xilio Therapeutics Inc
22 Oct 21
Prospectus supplement with pricing info
4:02pm
track product or regenerative medicine advanced therapy.
In addition, on May 30, 2018, the Right to Try Act was signed into law. The law, among other
S-1/A
XLO
Xilio Therapeutics Inc
18 Oct 21
IPO registration (amended)
6:04am
after the investigational drug or biologic receives designation as a Breakthrough Therapy, fast track product or regenerative medicine advanced therapy
S-1
XLO
Xilio Therapeutics Inc
1 Oct 21
IPO registration
4:49pm
product or regenerative medicine advanced therapy.
In addition, on May 30, 2018, the Right to Try Act was signed into law. The law, among other
DRS/A
w2qrdjqcm
14 Sep 21
Draft registration statement (amended)
12:00am
DRS
l8kly130 pzbhs1byzlx
24 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next